These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 23344183

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
    Shim YS, Youn YC, Na DL, Kim SY, Cheong HK, Moon SY, Park KW, Ku BD, Lee JY, Jeong JH, Kang H, Kim EJ, Lee JS, Go SM, Kim SH, Cha KR, Seo SW.
    Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
    [Abstract] [Full Text] [Related]

  • 3. Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease.
    Staekenborg SS, Gillissen F, Romkes R, Pijnenburg YA, Barkhof F, Scheltens P, van der Flier WM.
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):387-92. PubMed ID: 17907266
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.
    Kim JH, Hwang KJ, Kim JH, Lee YH, Rhee HY, Park KC.
    J Clin Neurosci; 2011 Aug; 18(8):1101-6. PubMed ID: 21723730
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Medial temporal lobe atrophy relates to executive dysfunction in Alzheimer's disease.
    Oosterman JM, Oosterveld S, Rikkert MG, Claassen JA, Kessels RP.
    Int Psychogeriatr; 2012 Sep; 24(9):1474-82. PubMed ID: 22717328
    [Abstract] [Full Text] [Related]

  • 11. Cerebral white matter disease is independently associated with BPSD in Alzheimer's disease.
    Kandiah N, Chander R, Zhang A, Yee CC.
    J Neurol Sci; 2014 Feb 15; 337(1-2):162-6. PubMed ID: 24378065
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Montreal cognitive assessment in assessing clinical severity and white matter hyperintensity in Alzheimer's disease with normal control comparison.
    Chang YT, Chang CC, Lin HS, Huang CW, Chang WN, Lui CC, Lee CC, Lin YT, Chen CH, Chen NC.
    Acta Neurol Taiwan; 2012 Jun 15; 21(2):64-73. PubMed ID: 22879115
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer's disease.
    Rodriguez MJ, Potter E, Shen Q, Barker W, Greig-Custo M, Agron J, Loewenstein D, Duara R.
    Alzheimers Dement; 2012 May 15; 8(3):211-8. PubMed ID: 22546353
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Blood pressure, white matter lesions and medial temporal lobe atrophy: closing the gap between vascular pathology and Alzheimer's disease?
    Korf ES, Scheltens P, Barkhof F, de Leeuw FE.
    Dement Geriatr Cogn Disord; 2005 May 15; 20(6):331-7. PubMed ID: 16179827
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.